Reactions 1664, p18 - 12 Aug 2017 Seizures: case report In a retrospective study, an infant [age and sex not stated] was identified, who developed seizures following off-label high dose treatment with aciclovir [acyclovir]. The infant with neonatal herpes simplex virus (HSV) infection localized to skin, eyes or mucous membranes, was started on treatment with high dose (off-label for infants) aciclovir [exact dosage and route not stated], developed seizures [duration of treatment to reaction onset and outcome not stated]. Author comment: "Five of the 8 infants who had a seizure had virologic confirmation of HSV: 2 had CNS disease, 2 had disseminated disease and 1 had [skin, eyes or mucous membranes] disease." "We identified 89 infants during the study period with 1658 days of acyclovir exposure. Almost all received high-dose acyclovir therapy (79/89, 89%). The most common clinical AEs were hypotension and seizure, both occurring in 9% of infants." Ericson JE, et al. Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections. Pediatric Infectious Disease Journal 36: 369-373, No. 4, Apr 2017. Available from: URL: http:// doi.org/10.1097/INF.0000000000001451 - USA 803262131 0114-9954/17/1664-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 12 Aug 2017 No. 1664
Reactions Weekly – Springer Journals
Published: Aug 12, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera